FGF
BPC-157
Body Protection Compound · Regeneration
From
$76.99
Research peptides used to investigate cell migration, angiogenesis, and tissue-healing pathways in preclinical models. The category centres on BPC-157 (Body Protection Compound), TB-500 (a synthetic fragment of Thymosin-beta-4), and a synergetic TB-500 plus BPC-157 blend that combines both mechanisms in a single vial and simplifies reconstitution in combination studies without altering the individual modes of action.
BPC-157 and TB-500 are frequently combined in the preclinical literature because they target different healing pathways. Available as individual vials or as a ready-to-use blend.
BPC-157 (Body Protection Compound) is a synthetic pentadecapeptide consisting of 15 amino acids, whose sequence is derived from a fragment of a human gastric protective protein. In preclinical studies BPC-157 is investigated in connection with cell migration, angiogenesis, and tissue-healing pathways. Research interest focuses on FGF-mediated signalling mechanisms as well as on effects that are discussed in the literature in relation to new vessel formation. BergdorfBio supplies BPC-157 strictly as a research tool; it is not approved for human or veterinary application in any context.
Recovery groups research peptides that are investigated in preclinical studies of cell migration, angiogenesis, and tissue healing. BPC-157 is a 15-amino-acid fragment derived from a human gastric protective protein and is commonly associated in the literature with FGF-mediated signalling pathways. TB-500 is a synthetic fragment of endogenous Thymosin-beta-4 and is used in studies on actin polymerisation as well as general cell motility. The blend combines both peptides in a single vial in order to simplify reconstitution in combination studies, while preserving the individual mechanisms of action and enabling a constant mixing ratio across the full study duration.
Every peptide in the Recovery category is tested by HPLC for a purity of at least 99 % and confirmed for identity by mass spectrometry. Certificates of analysis (CoA) are available on request and document the purity profile together with the molecular mass of the specific batch. For the TB-500 plus BPC-157 blend, the purity of each component is reported separately so that the mixing ratio remains transparent. All products are strictly Research Use Only (RUO) and are not approved for human or veterinary use. Documentation describes analytical characterisation only and makes no therapeutic or clinical claims.
The lyophilised peptides are stable at -20 degrees Celsius for up to 24 months when kept sealed and protected from humidity. For experiments they are typically reconstituted with bacteriostatic water; the resulting solution remains usable for 28 days at 2 to 8 degrees Celsius as long as sterile technique is maintained. The same parameters apply to the blend, where the stated concentration refers to the combined mass of both peptides in the vial. Light, repeated freeze-thaw cycles, and temperature fluctuations reduce stability. Detailed protocols on concentration and aliquoting are provided in the BPC-157 guide.
| gemischt |
| ≥99.0% |
| $113.99 |
| View → |
| Thymosin Alpha-1 | — | — | $114.99 | View → |